China Poised To Conditionally Approve First COVID Vaccine
New Guidelines Allow Early Clearance
Executive Summary
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.